Hostname: page-component-7479d7b7d-68ccn Total loading time: 0 Render date: 2024-07-10T19:59:59.489Z Has data issue: true hasContentIssue true

Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases

Published online by Cambridge University Press:  01 July 2010

E. McLEAN
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
R. G. PEBODY*
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
C. CAMPBELL
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
M. CHAMBERLAND
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
C. HAWKINS
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
J. S. NGUYEN-VAN-TAM
Affiliation:
University of Nottingham, UK
I. OLIVER
Affiliation:
Health Protection Agency, Local and Regional Services, UK
G. E. SMITH
Affiliation:
Health Protection Agency, Local and Regional Services, UK
C. IHEKWEAZU
Affiliation:
Health Protection Agency, Local and Regional Services, UK
S. BRACEBRIDGE
Affiliation:
Health Protection Agency, Local and Regional Services, UK
H. MAGUIRE
Affiliation:
Health Protection Agency, Local and Regional Services, UK
R. HARRIS
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
G. KAFATOS
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
P. J. WHITE
Affiliation:
Health Protection Agency, Centre for Infections, London, UK MRC Centre for Outbreak Analysis & Modelling, Imperial College London, UK
E. WYNNE-EVANS
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
J. GREEN
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
R. MYERS
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
A. UNDERWOOD
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
T. DALLMAN
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
T. WREGHITT
Affiliation:
Health Protection Agency, Regional Microbiology Network, UK
M. ZAMBON
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
J. ELLIS
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
N. PHIN
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
B. SMYTH
Affiliation:
Public Health Agency for Northern Ireland, Belfast, UK
J. McMENAMIN
Affiliation:
Health Protection Scotland, Glasgow, UK
J. M. WATSON
Affiliation:
Health Protection Agency, Centre for Infections, London, UK
*
*Author for correspondence: Dr R. Pebody, Health Protection Agency, Centre for Infections, 61 Colindale Avenue, London, NW9 5EQ. (Email: Richard.Pebody@hpa.org.uk)
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The UK was one of few European countries to document a substantial wave of pandemic (H1N1) 2009 influenza in summer 2009. The First Few Hundred (FF100) project ran from April–June 2009 gathering information on early laboratory-confirmed cases across the UK. In total, 392 confirmed cases were followed up. Children were predominantly affected (median age 15 years, IQR 10–27). Symptoms were mild and similar to seasonal influenza, with the exception of diarrhoea, which was reported by 27%. Eleven per cent of all cases had an underlying medical condition, similar to the general population. The majority (92%) were treated with antiviral drugs with 12% reporting adverse effects, mainly nausea and other gastrointestinal complaints. Duration of illness was significantly shorter when antivirals were given within 48 h of onset (median 5 vs. 9 days, P=0·01). No patients died, although 14 were hospitalized, of whom three required mechanical ventilation. The FF100 identified key clinical and epidemiological characteristics of infection with this novel virus in near real-time.

Type
Original Papers
Copyright
Copyright © Cambridge University Press 2010

References

REFERENCES

1.Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children – Southern California, March–April 2009. Morbidity and Mortality Weekly Report 2009; 58: 400402.Google Scholar
2.Centers for Disease Control and Prevention. Outbreak of swine-origin influenza A (H1N1) virus infection – Mexico, March–April 2009. Morbidity and Mortality Weekly Report 2009; 58: 467470.Google Scholar
3.Garten, RJ, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325: 197201.CrossRefGoogle ScholarPubMed
4.Health Protection Agency. Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April-June 2009. Eurosurveillance 2009; 14: pii=19232.Google Scholar
5.Health Protection Agency. Epidemiology of new influenza A(H1N1) in the United Kingdom, April–May 2009. Eurosurveillance 2009; 14: pii=19213.Google Scholar
6.Health Protection Agency. Pandemic (H1N1) 2009 in England: an overview of initial epidemiological findings and implications for the second wave, 24 November 2009 (http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1258560552857). Accessed 4 December 2009.Google Scholar
7.World Health Organization. Global surveillance during an influenza pandemic (http://www.who.int/csr/disease/swineflu/global_pandemic_influenza_surveilance_apr09.pdf). Accessed 15 February 2010.Google Scholar
8.McMenamin, J, et al. Minimum dataset for confirmed human cases of influenza H5N1. Lancet 2008; 372: 2022.CrossRefGoogle ScholarPubMed
9.Health Protection Agency. The First Few Hundred (FF100) Project. Epidemiological Protocols for Comprehensive Assessment of Early Swine Influenza Cases in the United Kingdom, 2009 (http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1257260453727). Accessed 4 December 2009.Google Scholar
10.Gates, P, et al. Collection of routine national seasonal influenza vaccine coverage data from GP practices in England using a web-based collection system. Vaccine 2009; 27: 66696677.CrossRefGoogle ScholarPubMed
11.National Centre for Social Research. National Survey of Sexual Attitudes and Lifestyles II, 2000–2001. 2005.Google Scholar
12.Ellis, J, Curran, M. Simultaneous molecular detection and confirmation of influenza AH5, with internal control. In: Stephenson, JR, Warnes, A, eds. Diagnostic Virology Protocols. Humana Press (in press).Google Scholar
13.Ellis, J, et al. Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Eurosurveillance 2009; 14: pii=19230.CrossRefGoogle ScholarPubMed
14.Calatayud, L, et al. Pandemic (H1N1) 2009 virus outbreak in a school in London, April–May 2009: an observational study. Epidemiology and Infection 2009; 138: 183191.CrossRefGoogle Scholar
15.Health Protection Agency West Midlands H1N1v Investigation Team. Preliminary descriptive epidemiology of a large school outbreak of influenza A(H1N1)v in the West Midlands, United Kingdom, May 2009. Eurosurveillance 2009; 14: pii=19264.Google Scholar
16.Kar-Purkayastha, I, et al. The importance of school and social activities in the transmission of influenza A(H1N1)v: England, April–June 2009. Eurosurveillance 2009; 14: pii=19311.CrossRefGoogle ScholarPubMed
17.Begum, F, Pebody, RG.Influenza vaccine uptake among the 65 years and over and under 65 years at risk in England, winter season 2008–09. 2009 (http://www.immunisation.nhs.uk/publications/FluVaccineUptake_Winter0809.pdf). Accessed 4 December 2009.Google Scholar
18.Ghani, AC, et al. The early transmission dynamics of H1N1pdm influenza in the United Kingdom. PLoS Currents: Influenza 2009; RRN1130.Google ScholarPubMed
19.Dawood, FS, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. New England Journal of Medicine 2009; 360: 26052615.Google ScholarPubMed
20.Centers for Disease Control and Prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Morbidity and Mortality Weekly Report 2009; 58: 521524.Google Scholar
21.Miller, E, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010; 375: 11001108.CrossRefGoogle Scholar
22.Nicholson, KG. Clinical features of influenza. Seminars in Respiratory Infections 1992; 7: 2637.Google ScholarPubMed
23.Presanis, AM, et al. The severity of pandemic H1N1 influenza in the United States, April–July 2009. PLoS Currents: Influenza 2009; RRN1042.Google ScholarPubMed
24.National Institute for Health and Clinical Excellence. Amantadine, oseltamivir and zanamivir for the treatment of influenza. Review of NICE technology appraisal guidance 58, 2009 (http://www.nice.org.uk/nicemedia/pdf/TA168fullguidance.pdf). Accessed 4 December 2009.Google Scholar
25.Aoki, FY, Boivin, G. Influenza virus shedding: excretion patterns and effects of antiviral treatment. Journal of Clinical Virology 2009; 44: 255261.CrossRefGoogle ScholarPubMed
26.Donaldson, LJ, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. British Medical Journal 2009; 339: b5213.CrossRefGoogle ScholarPubMed